Atlas Trials

A Study of LY573636-sodium in Patients With Metastatic Breast Cancer

Clinical trial NCT00992225 · COMPLETED

Trial details

NCT number
NCT00992225
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2009-09-01
Primary completion
2011-04-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.